Leading provider of disposable incontinence products now seeks qualified candidates to fill up to 50 positions
Mundelein, Ill., Sept. 30, 2016
The annual cost of central line-associated bloodstream infections (CLABSI) is more than $1 billion and vascular access devices (VADs) are the most frequent cause of healthcare-associated bloodstream infections. Clinicians can’t always count on the “scrub the hub” technique for prepping the line for entry. That’s why Medline offers the SwabFlush® line to help standardize infection prevention protocols.
Growing interest in the product recently led to 13 new customer deals, and $1 million in sales growth as a result of these new agreements.
SwabFlush is the only device that combines a saline flush syringe and disinfection cap. As a final flush it ensures that the disinfection cap is always readily available to protect the connector between line accesses. Additionally, the SwabCap is built into the syringe plunger to help achieve disinfection and protection of needleless connectors, and will disinfect the valve five minutes after application.
Visit www.medline.com for more information on the SwabFlush line.
Medline is a global manufacturer and distributor serving the healthcare industry with medical supplies and clinical solutions that help customers achieve both clinical and financial success. Headquartered in Mundelein, Ill., the company offers 350,000+ medical devices and support services through more than 1,200 direct sales representatives who are dedicated points of contact for customers across the continuum of care. For more information on Medline, go to www.medline.com or http://www.medline.com/social-media to connect with Medline on its social media channels.